Manika Suryadevara1, Cynthia A Bonville2, Donald A Cibula3, Matthew Valente2, Andrew Handel2, James R Domachowse4, Joseph B Domachowske2. 1. Department of Pediatrics, State University of New York Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, United States. Electronic address: suryadem@upstate.edu. 2. Department of Pediatrics, State University of New York Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, United States. 3. Department of Public Health and Preventive Medicine, State University of New York Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, United States. 4. UCLA School of Theater, Film, and Television, 225 Charles E Young Drive, Los Angeles, CA 90095, United States.
Abstract
BACKGROUND: Pertussis is a highly contagious vaccine preventable disease resulting in significant infant morbidity and mortality. Despite the recommendations for pertussis vaccine (Tdap) in adults, coverage rates in this age group remain suboptimal. We sought to determine factors associated with Tdap receipt among adults with children in the household who live in central New York. METHODS: The study team surveyed Tdap immunization status of adults who accessed medical services for their children provided by Golisano Children's Hospital, Syracuse, New York. Adults who did not know their Tdap vaccine status were excluded. Each participant was asked a standard set of questions to determine factors associated with Tdap receipt. Logistic regression was used to calculate simple and adjusted odds ratios for Tdap receipt in relation to adults' demographic characteristics, knowledge of Tdap and physician recommendations. RESULTS: Eight hundred twenty four participants were included in this study; 34% had received Tdap in the past 5 years; 58% reported that their provider or child's pediatrician recommended adult Tdap vaccination. Tdap receipt was associated with knowing the symptoms of pertussis infection, female gender, younger age, and provider recommendation (p<0.05). Participants whose provider recommended Tdap vaccine were 24.6 times more likely to receive vaccine when compared to those whose providers did not recommend vaccine (95% CI: 16.3, 37.2, p<0.05). CONCLUSION: Tdap coverage rates are low among this study population, with provider recommendation most strongly associated with Tdap receipt. Future steps to improve vaccine coverage should include both increasing community awareness and determining barriers to provider recommendation.
BACKGROUND: Pertussis is a highly contagious vaccine preventable disease resulting in significant infant morbidity and mortality. Despite the recommendations for pertussis vaccine (Tdap) in adults, coverage rates in this age group remain suboptimal. We sought to determine factors associated with Tdap receipt among adults with children in the household who live in central New York. METHODS: The study team surveyed Tdap immunization status of adults who accessed medical services for their children provided by Golisano Children's Hospital, Syracuse, New York. Adults who did not know their Tdap vaccine status were excluded. Each participant was asked a standard set of questions to determine factors associated with Tdap receipt. Logistic regression was used to calculate simple and adjusted odds ratios for Tdap receipt in relation to adults' demographic characteristics, knowledge of Tdap and physician recommendations. RESULTS: Eight hundred twenty four participants were included in this study; 34% had received Tdap in the past 5 years; 58% reported that their provider or child's pediatrician recommended adult Tdap vaccination. Tdap receipt was associated with knowing the symptoms of pertussis infection, female gender, younger age, and provider recommendation (p<0.05). Participants whose provider recommended Tdap vaccine were 24.6 times more likely to receive vaccine when compared to those whose providers did not recommend vaccine (95% CI: 16.3, 37.2, p<0.05). CONCLUSION:Tdap coverage rates are low among this study population, with provider recommendation most strongly associated with Tdap receipt. Future steps to improve vaccine coverage should include both increasing community awareness and determining barriers to provider recommendation.
Authors: Manika Suryadevara; Joshua R Bonville; Rachael M Kline; Colleen Magowan; Elizabeth Domachowske; Donald A Cibula; Joseph B Domachowske Journal: Hum Vaccin Immunother Date: 2016-02-02 Impact factor: 3.452
Authors: Liliana Sánchez-González; Alfonso Rodriguez-Lainz; Alissa O'Halloran; Ali Rowhani-Rahbar; Jennifer L Liang; Peng-Jun Lu; Peter M Houck; Stephane Verguet; Walter W Williams Journal: J Community Health Date: 2017-06
Authors: Edouard Ledent; Giovanni Gabutti; Esther W de Bekker-Grob; Juan Luis Alcázar Zambrano; Magda Campins Martí; María Teresa Del Hierro Gurruchaga; María José Fernández Cruz; Giuseppe Ferrera; Francesca Fortunato; Pierfederico Torchio; Giorgio Zoppi; Christian Agboton; Walid Kandeil; Federico Marchetti Journal: Hum Vaccin Immunother Date: 2019-04-15 Impact factor: 3.452
Authors: D M MacDougall; B A Halperin; D MacKinnon-Cameron; Li Li; S A McNeil; J M Langley; S A Halperin Journal: BMJ Open Date: 2015-09-29 Impact factor: 2.692